Literature DB >> 23597580

Two stages of programming eye gaze shifts in 3-D space.

L Pérez Zapata1, J A Aznar-Casanova, H Supèr.   

Abstract

Accurate saccadic and vergence eye movements towards selected visual targets are fundamental to perceive the 3-D environment. Despite this importance, shifts in eye gaze are not always perfect given that they are frequently followed by small corrective eye movements. The oculomotor system receives distinct information from various visual cues that may cause incongruity in the planning of a gaze shift. To test this idea, we analyzed eye movements in humans performing a saccade task in a 3-D setting. We show that saccades and vergence movements towards peripheral targets are guided by monocular (perceptual) cues. Approximately 200ms after the start of fixation at the perceived target, a fixational saccade corrected the eye positions to the physical target location. Our findings suggest that shifts in eye gaze occur in two phases; a large eye movement toward the perceived target location followed by a corrective saccade that directs the eyes to the physical target location.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23597580     DOI: 10.1016/j.visres.2013.04.005

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  3 in total

1.  Attention-Related Eye Vergence Measured in Children with Attention Deficit Hyperactivity Disorder.

Authors:  Maria Solé Puig; Laura Pérez Zapata; Laura Puigcerver; Neus Esperalba Iglesias; Carmen Sanchez Garcia; August Romeo; Josep Cañete Crespillo; Hans Supèr
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

2.  The efference cascade, consciousness, and its self: naturalizing the first person pivot of action control.

Authors:  Bjorn Merker
Journal:  Front Psychol       Date:  2013-08-09

3.  Difference in visual processing assessed by eye vergence movements.

Authors:  Maria Solé Puig; Laura Puigcerver; J Antonio Aznar-Casanova; Hans Supèr
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.